{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-002731","form_type":"8-K","ticker":"DYN","cik":"0001818794","company_name":"Dyne Therapeutics, Inc.","filed_at":"2022-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.412627+00:00","generated_at":"2026-06-27T02:06:20.187143+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Dyne Therapeutics elects Carlo Incerti, M.D. to Board of Directors","bullets":["Dr. Incerti elected as Class I director, term expiring at 2024 annual meeting.","Received option to purchase 39,139 shares at $8.69 per share (March 2 closing price).","Option vests in equal monthly installments over three years; full acceleration on change of control.","Annual cash compensation of $35,000 plus standard director equity grants and expense reimbursement.","Board determined Dr. Incerti is an independent director under Nasdaq rules."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-002731","json":"https://secwatch.observer/filing/0000950170-22-002731.json","markdown":"https://secwatch.observer/filing/0000950170-22-002731.md","text":"https://secwatch.observer/filing/0000950170-22-002731.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818794/000095017022002731/0000950170-22-002731-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818794/000095017022002731/dyn-20220302.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T02:06:20.187143+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2e9605c202","claim":"Carlo Incerti was elected as Director at Dyne Therapeutics, Inc..","evidence_excerpt":"On March 2, 2022, the Board of Directors (the “Board”) of Dyne Therapeutics, Inc. (the “Company”), upon recommendation from the Nominating and Corporate Governance Committee of the Board, elected Carlo Incerti, M.D. as a Class I director to serve on the Board until the Company’s 2024 Annual Meeting of Stockholders and until his successor has been duly elected and qualified or until his earlier death, resignation or removal.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1818794/000095017022002731/0000950170-22-002731-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}